Literature DB >> 11413049

Cubilin and megalin: partners in lipoprotein and vitamin metabolism.

J L Barth1, W S Argraves.   

Abstract

Members of the low-density lipoprotein receptor (LDLR) family are unrivalled for their ability to endocytose and target ligands to lysosomes for degradation. Their endocytic and catabolic functions make them essential to homeostatic regulation of the level and activity of their ligands in biological fluids and interstitial spaces. Over the last few years it has become evident that the endocytic function of members of the LDLR family is employed by other kinds of cell surface receptors. Recently, the low-density lipoprotein receptor related protein-2 (megalin) was shown to act in concert with cubilin, a receptor for high-density lipoproteins (HDL)/apolipoprotein A-I (apoA-I), intrinsic factor-vitamin B12 and albumin to mediate ligand endocytosis. In this article, we review the state of knowledge pertaining to cubilin and megalin, emphasizing their joint roles in both lipoprotein and vitamin metabolism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11413049     DOI: 10.1016/s1050-1738(01)00080-9

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  20 in total

1.  Cubilin and megalin in radiation-induced renal injury with labelled somatostatin analogues: are we just dealing with the kidney?

Authors:  R Moncayo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10       Impact factor: 9.236

2.  Afamin is synthesized by cerebrovascular endothelial cells and mediates alpha-tocopherol transport across an in vitro model of the blood-brain barrier.

Authors:  Ingrid Kratzer; Eva Bernhart; Andrea Wintersperger; Astrid Hammer; Sabine Waltl; Ernst Malle; Günther Sperk; Georg Wietzorrek; Hans Dieplinger; Wolfgang Sattler
Journal:  J Neurochem       Date:  2008-11-27       Impact factor: 5.372

3.  Cubilin maintains blood levels of HDL and albumin.

Authors:  Obaidullah Aseem; Brian T Smith; Marion A Cooley; Brent A Wilkerson; Kelley M Argraves; Alan T Remaley; W Scott Argraves
Journal:  J Am Soc Nephrol       Date:  2013-12-19       Impact factor: 10.121

4.  Oral administration of a GSK3 inhibitor increases brain insulin-like growth factor I levels.

Authors:  Marta Bolós; Silvia Fernandez; Ignacio Torres-Aleman
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

5.  Cholesteryl ester transfer protein (CETP) expression enhances HDL cholesteryl ester liver delivery, which is independent of scavenger receptor BI, LDL receptor related protein and possibly LDL receptor.

Authors:  Hongwen Zhou; Zhiqiang Li; David L Silver; Xian-Cheng Jiang
Journal:  Biochim Biophys Acta       Date:  2006-09-20

6.  The effect of progressive glomerular disease on megalin-mediated endocytosis in the kidney.

Authors:  Lotte Vinge; George E Lees; Rikke Nielsen; Clifford E Kashtan; Anne Bahr; Erik I Christensen
Journal:  Nephrol Dial Transplant       Date:  2010-03-02       Impact factor: 5.992

7.  Western style diet impairs entrance of blood-borne insulin-like growth factor-1 into the brain.

Authors:  Marcelo O Dietrich; Alexandre Muller; Marta Bolos; Eva Carro; Marcos L Perry; Luis V Portela; Diogo O Souza; Ignacio Torres-Aleman
Journal:  Neuromolecular Med       Date:  2007-09-05       Impact factor: 3.843

8.  Retinoids modulate expression of the endocytic partners megalin, cubilin, and disabled-2 and uptake of vitamin D-binding protein in human mammary cells.

Authors:  Timothy M Chlon; David A Taffany; Joellen Welsh; Matthew J Rowling
Journal:  J Nutr       Date:  2008-07       Impact factor: 4.798

9.  Cubilin, a high affinity receptor for fibroblast growth factor 8, is required for cell survival in the developing vertebrate head.

Authors:  Olivier Cases; Aitana Perea-Gomez; Diego P Aguiar; Anders Nykjaer; Sabine Amsellem; Jacqueline Chandellier; Muriel Umbhauer; Silvia Cereghini; Mette Madsen; Jérôme Collignon; Pierre Verroust; Jean-François Riou; Sophie E Creuzet; Renata Kozyraki
Journal:  J Biol Chem       Date:  2013-04-16       Impact factor: 5.157

Review 10.  Lipoprotein metabolism in chronic renal insufficiency.

Authors:  Jeffrey M Saland; Henry N Ginsberg
Journal:  Pediatr Nephrol       Date:  2007-03-28       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.